iTBS to Enhance Social Cognition in People With Psychosis
NCT06118268
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to examine if iTBS applied to the DMPFC improves social cognitive performance compared to sham stimulation in people diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, or psychotic disorder not otherwise specified. The main objectives of this trial are: Compare changes in social cognitive performance between the active vs. sham treatment groups Compare changes in social cognitive network functional connectivity between the active vs.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Schizophrenia
- Schizo Affective Disorder
- Schizophreniform Disorders
- Psychosis Nos/Other
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 39 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Northwell Health
- Last updated on ClinicalTrials.gov
- October 8, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Zucker Hillside Hospital · Glen Oaks, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.